This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Managing Hyperkalemia in the Inpatient Setting: <em>Evolving Strategies to Ensure Optimal Patient Outcomes</em>

Managing Hyperkalemia in the Inpatient Setting: Evolving Strategies to Ensure Optimal Patient Outcomes


Patient Case Study

Time to Complete

1 hour


October 19, 2017


October 19, 2018
Add to Queue

Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurses

Accredited Provider

This activity is jointly provided by Global Education Group and ASiM.

Commercial Supporter

Supported by an educational grant from ZS Pharma, Inc.

Program Description

Hyperkalemia occurs in up to 10% of hospitalized patients and is associated with increased morbidity and mortality if left unaddressed. As a result, it is crucial to recognize and treat this electrolyte imbalance to optimize patient outcomes. Limited treatment options have rendered inpatient hyperkalemia management suboptimal; however, recently, several approved and investigational treatment options and strategies offer new options to patients with this electrolyte imbalance, changing the landscape of hyperkalemia treatment. Hospitalists, advanced practice nurses, healthcare practitioners, and other hospital-based providers play a crucial role in both recognizing hyperkalemia and offending agents and in the treatment of patients diagnosed with hyperkalemia. This enduring roundtable activity will highlight recent advances in hyperkalemia pharmacotherapy and evaluate comprehensive strategies to recognize and manage hyperkalemia in clinical practice.

Intended Audience

This activity has been designed to meet the educational needs of hospitalists, advanced practice nurses, pharmacists, and other hospital-based providers who are involved in the care of patients who present with or are at-risk for hyperkalemia. No prerequisites required.

Educational Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Recognize precipitating factors, including clinical conditions and medication therapy that contribute to the development of hyperkalemia.
  • Identify novel hyperkalemia agents and how they compare with conventional treatment options.
  • Formulate treatment plans for correcting hyperkalemia according to etiology and physiology.

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity under the Faculty heading below.


Bentley C. Tate, MD (Moderator)
Director of Emergency Department
Colorado Plains Medical Center
Fort Morgan, CO

Dr. Tate has nothing to disclose.

Cynthia Bither, ACNP, ANP, MSN, AACC, CHFN
Chief Nurse Practitioner
Advanced Heart Failure Program
MedStar Washington Hospital Center
Washington, DC

Ms. Bither has indicated that she is on the Speaker’s Bureau and Advisory Board (for a one-time meeting) at Medtronic and Novartis.

Darla Klug Eastman, PharmD, BCPS
Associate Professor of Clinical Sciences
Drake University College of Pharmacy and Health Sciences
Clinical Pharmacist, Trauma and General Surgery
Iowa Methodist Medical Center
Des Moines, IA

Dr. Eastman has nothing to disclose.

Mazen Hanna, MD
Director, Heart Failure Intensive Care Unit
Co-Director, Amyloid Program
Cleveland Clinic
Department of Cardiovascular Disease
Cleveland, OH

Dr. Hanna has nothing to disclose.

Planners and Managers Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Ankita Patel, PharmD, has nothing to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Advanced Studies in Medicine. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.




CE for Nurses

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and ASiM CE, LLC, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.


In order to receive credit, participants must complete the pre-assessment questions, post-test, and program evaluation. Participants must also score at least 70% on the posttest. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or

If you have any other questions relating to your certificate or other issues with the activity, please contact


All rights reserved. No part of this syllabus may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue